Nicholas Investment Partners, LP Fibrogen Inc Transaction History
Nicholas Investment Partners, LP
- $912 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding FGEN
# of Institutions
81Shares Held
39.9MCall Options Held
343KPut Options Held
100K-
Armistice Capital, LLC New York, NY6.8MShares$3.74 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.88MShares$3.23 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA4.62MShares$2.54 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$2.15 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$1.33 Million0.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $51.6M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...